ExCEEd Orphan will continue next year in cooperation with Novartis Gene Therapies (previously
Tag: genetherapy
AveXis receives EC approval for Zolgensma®
AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the
First SMA Patient in Czechia was treated with gene therapy in Faculty Hospital in Motol
Little Max is the first patient with spinal muscular atrophy who received systemic
Gene Therapy reimbursed for SMA patients in Czechia
捷克健康保险公司最近批准reimbursement of breakthrough gene therapy treatment for
AveXis receives positive CHMP opinion for Zolgensma®
AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®
Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®